Finished
Assessing the Benefits of Robotic and Laparoscopic Surgery for Mid and Low Rectal Cancer in Patients: The Charlson Comorbidity Index (CCI)
NCT06396845 · Daorong Wang · Updated 2 May 2024
- What is being tested
- robotic surgery; laparoscopic surgery
- For
- Robotic; Laparoscopic; Anterior Resection for Rectal Cancer
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 55 years to 85 years. About 505 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 Jan 2019, ends 3 Jan 2024. Registered 2 May 2024.
- Results
- None posted yet.
In the researchers' words
This retrospective study collected participants who underwent robotic or laparoscopic anterior resection for rectal cancer at the North People's Hospital in Jiangsu from January 2019 to January 2023.
Sites
- Northern Jiangsu People's HospitalYangzhou, Jiangsu, China